Information about Apr Pharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0748.905.227

VAT liability
Yes
Established
24-06-2020
Last balance sheet year
2025
Company size
Micro 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Manufacture of basic pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Apr Pharma

2025 2024 2023 2022
Income statement
Profit/Loss € 39,279 239% € -28,220 -1% € -27,926 86% € -197,624
Gross margin € 70,657 > 1000% € -667 73% € -2,511 99% € -172,247
Balance sheet
Balance sheet total € 244,955 -7% € 263,063 10% € 239,168 -23% € 309,780
Equity € 93,506 > 1000% € 4,227 -87% € 32,447 -46% € 60,373
Debts € 151,449 -41% € 258,836 25% € 206,721 -17% € 249,407

Publications from Apr Pharma

Date Publication
10-11-2025 Miscellaneous (FR)
26-06-2020 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Apr Pharma?
The VAT number of Apr Pharma is BE 0748.905.227.
Wat is the PEPPOL ID of Apr Pharma?
The PEPPOL ID of Apr Pharma is 0208:0748905227. Log in or start a free trial to see the full overview.
When was Apr Pharma founded?
Apr Pharma was founded on 24-06-2020.
What is the address of Apr Pharma?
The current registered office of Apr Pharma is located at Rue de Liège(co) 2, 6180 Courcelles.
When was the last time Apr Pharma filed their annual financial statements?
The most recent financial statements of Apr Pharma were filed on 21-08-2026.
How many employees does Apr Pharma have?
There are currently no employees working at Apr Pharma or no workforce information is available.
What is the annual turnover of Apr Pharma?
At the time of its most recent financial statements, Apr Pharma did not publish any turnover figures. Apr Pharma reported a gross margin of €70,657.48.